Volume : 08, Issue : 05, May – 2021
Title:
40.NANOSPONGES
Authors :
Nagulapati Sailaja*, Meka Anvitha, Chamarthi Sunitha, Shaik Sabiha Bhanu, B. Prashanti, G.Madhavi and K.Padmalatha
Abstract :
Nanosponges are a novel class of hyper-crosslinked polymer based colloidal structures consisting of solid nanoparticles with colloidal sizes and nanosized cavities in which wide varieties of drugs can be encapsulated. They are capable of encapsulating both lipophilic and hydrophilic drugs. In this review article, characteristics, advantages, disadvantages, factors affecting nanosponge formation, method of preparation, characterization of nanosponges and applications are discussed.
Key words: Nanosponges, drug delivery, nanotechnology
Cite This Article:
Please cite this article in press Nagulapati Sailaja et al., Nanosponges.., Indo Am. J. P. Sci, 2021; 08(05).
Number of Downloads : 10
References:
1. Recent Advances in Nanosponges as Drug Delivery System. Uday B Bolmal,Rajkumar Kotha, Anusha Paladugu. International journal of pharmaceutical sciences and nanotechnology.Vol 6 No1 (2013) April-June 2013
2. Nanosponges – a completely new nano-horizon: pharmaceutical applications and recentadvances. RanaZ.Ahmed, Gujanpatil and Zahid Zaheer. Drug development and industrial pharmacy. Volume 39, 2013 – Issue 9
3. David F. Nanosponge drug delivery system more effective than direct injection.www.physorg.com 01.06.2010, accessed on 20.12.2011.
4. Trotta F, Tumiatti V, Cavalli R, Rogero C, Mognetti B, Berta G. Cyclodextrin-basednanosponges as a vehicle for Antitumoral drugs. WO 2009/003656 A1; 2009.
5. Eki, T. Lei, L. Jingquan, J. Zhongfan, B. Cyrille and P. D. Thomas, Biodegradable starpolymers functionalized with b-cyclodextrin inclusion complexes, Biomacromolecules,10(2009) 2699– 2707;
6. E. Patel and R. Oswal, Nanosponge and micro sponges: a novel drug delivery system, Int. J. Res.Pharm. Chem. 2 (2012) 237–244.
7. S. Swaminathan, R. Cavalli, F. Trotta, P. Ferruti, E. Ranucci, I. Gerges, A. Manfredi, D. Marinotto andP. Vavia, In vitro release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of b-cyclodextrin, J. Incl. Phenom. Macrocycl. Chem. 68(2010) 183–191; DOI: 10.1007/s10847-010-9765-9.
8. Jenny A, Merima P, Alberto F, Francesco T. Role of β- cyclodextrin nanosponges in polypropylenephotooxidation. Carbohydrate Polymers, 2011; 86: 127– 135.
9. Khalid AA, Pradeep RV, Francesco T, Roberta C. Cyclodextrin-based nanosponges for delivery of Resveratrol: In Vitro characterisation, stability, cytotoxicity and permeation Study AAPSPharmSciTech, 2011; 12(1): 279-286.
10. T. Girek and W. Ciesielski, Polymerization of b-cyclodextrin with maleic anhydride along with thermogravimetric study of polymers, J. Incl. Phenom. Macrocycl. Chem. (2010) 1–7; DOI: 1007/s10847-010-9778-4.
11. R. Cavalli, F. Trotta and W. Tumiatti, Cyclodextrin-based nanosponges for drug delivery, J. Incl.Phenom. Macrocycl. Chem. 56 (2006) 209–213.F. Trotta, V. Tumiatti, R. Cavalli, C. Roggero, B. Mognetti and G. Berta, Cyclodextrin-based Nanosponges as a Vehicle for Antitumoral Drugs, WO 2009/003656 A1; 2009.
16 Mele, F. Castiglione, L. Malpezzi, F. Ganazzoli, G. Raffaini, F. Trotta, B. Rossi, A. Fontana and G.Giunchi, HR MAS NMR, powder XRD and Raman spectroscopy study of inclusion phenomena in β-CD nanosponges, J. Incl. Phenom. Macrocycl. Chem. 69 (2011) 403–409.
17 S. Torne, K. Ansari, P. Vavia, F. Trotta and R. Cavalli, Enhanced oral bioavailability afteradministration of paclitaxel-loaded nanosponges, Drug Deliv. 17 (2010) 419–425;
18 D. Li and M. Ma, Nanosponges: From inclusion chemistry to water purifying technology, Chem.Sci. Technol. (1999) 26–28.
19 Jenny A, Merima P, Alberto F, Francesco T. Role of β- cyclodextrin nanosponges in polypropylene photooxidation. Carbohydrate Polymers, 2011; 86: 127– 135.
20 Lala R, Thorat A, Gargote C. Current trends in βcyclodextrin based drug delivery systems. Int J ResAyur Pharm, 2011; 2(5): 1520-1526.
21 Trotta F, Cavalli R, Tumiatti W, Zerbinati O, Rogero C, Vallero R. Ultrasound-assisted synthesis of Cyclodextrin-based nanosponges. EP 1 786 841 B1; 2007.
22 Gupta J, Prabakaran L, Gupta R and Mohan G. Nanoparticles formulation using counterion induced gelification technique: in-vitro Chloramphenicol release. Int J Pharm PharmSci, 2011; 3(3):66-70.
23 Wong VN, Fernando G, Wagner AR, Zhang J, Kinsel GR, Zauscher S, Dyer DJ. Separation of peptides with polyionic nanosponges for MALDIMS analysis. Langmuir, 2009; 25(3):1459-65.
24 Ramnik S, Nitin B, Jyotsana M, Horemat SN. Characterization of Cyclodextrin Inclusion complexes –A Review. J Pharm Sci Tech, 2010; 2(3):171-183.
25 .Renuka S, Roderick BW, Kamla P. Evaluation of the kinetics and mechanism of drug release from Econazole Nitrate nanosponge loaded carbapol hydrogel. Ind J ParmEdu Res, 2011; 45(1): 25- 31.
26 Renuka S, Kamla P. Polymeric nanosponges as an alternative carrier for improved retention ofeconazole nitrate onto the skin through topical hydrogel formulation Pharm Dev Technol. 2011;16(4):367-376.
27 Gilardi G, Trota F, Cavalli R, Ferruti P, Ranucci E, Di Nardo G, Roggero C, Tumiatti V. Cyclodextrin nanosponges as carrier for biocatalysts, and in the delivery and release of enzymes, proteins,vaccines and antibodies. WO2009149883 A1; 2009.